vilobelimab
Generic: vilobelimab·Brand: Gohibic
vilobelimab: 1 clinical trial tracked.
vilobelimab evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about vilobelimab, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma Gangrenosum
Primary endpoint: Efficacy of treatment with vilobelimab compared to placebo
InterventionalRandomizedquadruple54 targetStarted 2023-11Completion 2025-0750 sites · Australia, Belgium, France, Germany…InflaRx GmbH